PsychedelicNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) (FSE: 8FW) to Present at Upcoming H.C. Wainwright Psychedelics Conference
Jun 2, 2021
Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (FSE: 8FW), a pharmaceutical company focused on developing compounds for diseases with unmet medical needs through accelerated regulatory pathways, has announced that it will be presenting at H.C. Wainwright & Co.’s Psychedelics in Psychiatry and Beyond conference. The virtual event will be held on June 17, 2021. At the elite conference, Tryp chair and CEO Greg McKee will present an overview of the business including the company’s pipeline, which features its psilocybin-for-neuropsychiatric disorders, or PFN(TM) (“PFN”), program for chronic pain and eating disorder indications. McKee’s prerecorded presentation will be available beginning 7 a.m. EDT on the day of the conference. In addition, Tryp announced the adoption of a new form of stock option plan designed to align with certain U.S. regulatory requirements pursuant to the U.S. Internal Revenue Code. As a result, some company directors and officers who were granted stock options under the prior plan have requested that those options be cancelled and re-issued under the new plan. Tryp has obtained approval from the Canadian Securities Exchange for the move.
To register for the event, visit https://ibn.fm/DkhtI
To view the full press release, visit https://ibn.fm/QrWpF
About Tryp Therapeutics Inc.
Tryp Therapeutics is a pharmaceutical company focused on developing compounds for the treatment of diseases with accelerated regulatory pathways. Tryp’s psilocybin-for-neuropsychiatric disorders, or PFN(TM) (“PFN”), program is focused on the development of synthetic psilocybin as a new class of drug for the treatment of certain neuropsychiatric-based disorders. Tryp’s lead PFN drug candidate is TRP-8802 for the treatment of fibromyalgia, a chronic pain syndrome estimated to affect more than five million people in the United States. The company is also preparing to initiate a phase 2a clinical study for eating disorders in partnership with the Dr. Jennifer Miller at the University of Florida. For more information about the company, please visit www.TrypTherapeutics.com.
NOTE TO INVESTORS: The latest news and updates relating to Tare available in the company’s newsroom at https://ibn.fm/TRYPF
About PsychedelicNewsWire
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.
To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.PsychedelicNewsWire.com
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer
Do you have questions or are you interested in working with PNW? Ask our Editor
PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
[email protected]
PsychedelicNewsWire is part of the InvestorBrandNetwork.
More News
Inflation and government borrowing highest for a year ahead of next week's Budget
Inflation accelerated to 3.5% from 3.1% in the year to September, according to the Office for National Statistics (ONS).
Senator Asks 4 Accounting Giants to Describe Malta Tax Advice
Ron Wyden, ranking Democrat on the Senate Finance Committee, is investigating the firms over their role in helping corporations dodge billions in taxes.
A Battle for Control of India’s Biggest Business Empire
A boardroom fight, an attempted veto and government intervention have plunged the Tata Group, one of India’s most revered institutions, into a fight over its future.
For an Experiment in Political Affirmative Action, Look to Taiwan
The island adopted quotas for women running for public office decades before other countries. The upshot? Today, few of them need quotas to get elected.
Elon Musk confirms he is considering merging Tesla and SpaceX
Musk says special committees within both companies have been formed to look at a possible mega-merger.
What is happening to UK prices?
UK inflation rose in September, pushed up by higher petrol and diesel prices.
Why is Elon Musk plotting a mega-merger of SpaceX and Tesla?
Musk says there's "a lot to be gained" by combining the firms in what would be the biggest merger in history.
Watch: 'We don't pay' - lawyer advises how to avoid £45,000 illegal-worker fine
Mohammad Alias Yousaf made his claim to an undercover reporter posing as a mini-mart owner.
The tech helping crack decades-old cold cases
Investigative genetic genealogy can help hunt down criminals but raises worries over privacy.
Netflix Is Great at Making Money. Its Problem Is Keeping Viewers Hooked.
The streaming service reported a 12 percent increase in quarterly revenue, but acknowledged that stagnant viewership, particularly in the U.S. and Canada, was a major concern.
SpaceX Swings to a Profit, as A.I. Business Grows
Elon Musk’s rocket company said its artificial intelligence spending had soared, but revenue more than doubled from its Starlink internet satellite service and A.I. products.
Audit regulator looking into Manchester City accounting
No formal investigation has started, but the regulator is making inquiries into the case.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.